|
1
|
Androgen-androgen receptor system protects against angiotensin II-induced vascular remodeling.
|
Endocrinology
|
2009
|
0.98
|
|
2
|
Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency.
|
Circ Res
|
2007
|
0.97
|
|
3
|
Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
|
Hypertension
|
2010
|
0.94
|
|
4
|
Androgen receptor counteracts Doxorubicin-induced cardiotoxicity in male mice.
|
Mol Endocrinol
|
2010
|
0.94
|
|
5
|
Ezetimibe ameliorates metabolic disorders and microalbuminuria in patients with hypercholesterolemia.
|
J Atheroscler Thromb
|
2010
|
0.90
|
|
6
|
Heparin cofactor II protects against angiotensin II-induced cardiac remodeling via attenuation of oxidative stress in mice.
|
Hypertension
|
2010
|
0.85
|
|
7
|
High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension.
|
Hypertens Res
|
2010
|
0.84
|
|
8
|
Androgen receptor promotes sex-independent angiogenesis in response to ischemia and is required for activation of vascular endothelial growth factor receptor signaling.
|
Circulation
|
2013
|
0.84
|
|
9
|
Heparin cofactor II is an independent protective factor against peripheral arterial disease in elderly subjects with cardiovascular risk factors.
|
J Atheroscler Thromb
|
2009
|
0.77
|
|
10
|
Activation of peroxisome proliferator-activated receptor α in megakaryocytes reduces platelet-derived growth factor-BB in platelets.
|
J Atheroscler Thromb
|
2010
|
0.77
|
|
11
|
Effect of low-dose (1 mg/day) pitavastatin on left ventricular diastolic function and albuminuria in patients with hyperlipidemia.
|
Am J Cardiol
|
2011
|
0.76
|